Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 870 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products872.42100%1,173100% +25.62%
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States792.5290.8%1,00785.9% +21.33%
Europe61.847.1%126.7210.8% +51.2%
All Other18.062.1%38.763.3% +53.41%
Ireland-----
Italy-----
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA512012Chairman & Chief Executive Officer
Russell J. Cox522012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA462013Chief Financial Officer & Executive Vice President
Mark G. Eller, PhD-2012Senior VP-Research & Clinical Development
Karen L. Smith MD, PhD-2015Chief Medical Officer & Global Head-Research
Paul L. Berns482010Independent Director
Bryan C. Cressey, MBA642012Independent Director
Patrick G. Enright, MBA532012Independent Director
Seamus C. Mulligan532012Director
Ken W. O'Keefe, MBA482012Independent Director
Shareholders
NameShares%
Fidelity Management & Research Co. 8,714,681 14.2%
Putnam Investment Management LLC 8,408,526 13.7%
The Vanguard Group, Inc. 3,875,233 6.33%
BlackRock Fund Advisors 2,967,785 4.85%
Westfield Capital Management Co. LP 2,361,458 3.86%
BT Investment Management Ltd. (Investment Management) 1,855,575 3.03%
Janus Capital Management LLC 1,566,276 2.56%
SSgA Funds Management, Inc. 1,182,963 1.93%
Seamus C. Mulligan 1,158,515 1.89%
Wellington Management Co. LLP 933,063 1.52%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
CELGENE CORPORATI..
ASTRAZENECA PLC
BIOGEN INC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
WALVAX BIOTECHNOL..
-
INDIVIOR PLC
MEDY TOX INC
CHONGQING ZHIFEI ..
-
AMAG PHARMACEUTIC..
GREEN CROSS CORP
ABCAM PLC
THERAVANCE INC
CELLDEX THERAPEUT..
Sector Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Aeglea Biotherapeutics, Inc.
Assistive Technology Group, Inc.
Cressey & Co. Llc
Vascular Cures
Thoma Cressey Bravo, Inc.
Circ Pharma Ltd.
Cressey & Co. LP
Stanford Health Care
Nueva School
Xanodyne Pharmaceuticals, Inc.
Sutrovax, Inc.
InfaCare Pharmaceutical Corp.
Select Medical Corp.
Raven Biotechnologies, Inc.
InfuScience, Inc.
Longitude Capital Management Co. LLC
Junior Achievement of Chicago
Beecken Petty O'Keefe & Co. LP
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2015 People , Fundamentals and Ownership